N01.5
Rapidly progressive nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
Clinical Classification Guidelines
Inclusion Terms
- Rapidly progressive nephritic syndrome with membranoproliferative glomerulonephritis, types 1 and 3, or NOS
Excludes Type 1
- Rapidly progressive nephritic syndrome with C3 glomerulonephritis (N01.A)
- Rapidly progressive nephritic syndrome with C3 glomerulopathy (N01.A)
Medical Intelligence & Overview
Rapidly progressive nephritic syndrome is a severe kidney condition characterized by a swift decline in kidney function. When associated with diffuse mesangiocapillary glomerulonephritis, also known as membranoproliferative glomerulonephritis types 1 and 3, it can lead to kidney failure if not diagnosed and managed promptly. This condition involves inflammation and damage to the glomeruli, which are tiny filtering units in the kidneys responsible for removing waste from the blood.
Causes & Symptoms
Clinical Causes: Immune system abnormalities leading to immune complex deposits in the glomeruli Infections such as hepatitis B or C, or endocarditis Other autoimmune diseases like lupus erythematosus Certain infections or diseases that trigger immune responses damaging the kidneys Idiopathic causes, where the specific reason remains unknown
Key Symptoms: Blood in the urine (hematuria) Foamy or bubbly urine due to excess protein (proteinuria) Swelling in the legs, ankles, or around the eyes (edema) High blood pressure Reduced urine output Fatigue and weakness General malaise or feeling unwell Fever or signs of infection in some cases
Diagnostic & Treatment
Diagnosis Path: Urinalysis to detect blood and protein levels Blood tests to assess kidney function (serum creatinine and BUN) Serological tests for infections or autoimmune markers Imaging studies like ultrasound to visualize kidney size and structure Kidney biopsy to confirm the presence of mesangiocapillary glomerulonephritis and assess the extent of damage
Treatment Protocols: Immunosuppressive medications such as corticosteroids and other agents Medications to control blood pressure, often including ACE inhibitors or ARBs Plasmapheresis in certain cases to remove immune complexes from the blood Treating underlying infections if identified Lifestyle modifications like a low-sodium, kidney-friendly diet Dialysis in cases where kidney failure develops
Clinical Advice & FAQs
Billing Guidance
Is N01.5 a billable ICD-10 code?
Yes, N01.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N01.5?
Clinical documentation must specify the nature of Rapidly progressive nephritic syndrome with diffuse mesangiocapillary glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference